Q&A with Verici Dx CEO, Sara Barrington & Chief Medical Officer, Dr Michael Donovan
Following yesterday’s positive operating update from Verici Dx, CEO Sara Barrington & Chief Medical Officer Dr. Michael Donovan take Vox through:
Commercial launch of #VRCI’s 1st kidney transplant test. 00:00
CMO role. 01:55
Key USPs & clinical benefits of Tutivia. 03:35
Improved accuracy of test. 08:30
Initial doctor feedback. 12:15
Significance of CLIA certificate for testing laboratory. 14:15
Update on Clarava. 16:50
Synergies from offering a suite of kidney transplant tests. 20:55
Size of the addressable market. 26:50
Cash runway & possible strategic options. 28:00
Future newsflow. 31:05
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.